Cardiovascular Disease Risk in Young People with Type 1 Diabetes

Article

Abstract

Cardiovascular disease (CVD) is the most frequent cause of death in people with type 1 diabetes (T1D), despite modern advances in glycemic control and CVD risk factor modification. CVD risk identification is essential in this high-risk population, yet remains poorly understood. This review discusses the risk factors for CVD in young people with T1D, including hyperglycemia, traditional CVD risk factors (dyslipidemia, smoking, physical activity, hypertension), as well as novel risk factors such as insulin resistance, inflammation, and hypoglycemia. We present evidence that adverse changes in cardiovascular function, arterial compliance, and atherosclerosis are present even during adolescence in people with T1D, highlighting the need for earlier intervention. The methods for investigating cardiovascular risk are discussed and reviewed. Finally, we discuss the observational studies and clinical trials which have thus far attempted to elucidate the best targets for early intervention in order to reduce the burden of CVD in people with T1D.

Keywords

Type 1 diabetes Cardiovascular disease Subclinical atherosclerosis Adolescents Insulin resistance Inflammation Cardiovascular function Carotid intima-media thickness Physical activity Hypertension Nephropathy Cardiovascular mortality 

References

  1. 1.
    Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003). Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia, 46(6), 760–765. doi:10.1007/s00125-003-1116-6.PubMedGoogle Scholar
  2. 2.
    Dorman, J. S., Laporte, R. E., Kuller, L. H., Cruickshanks, K. J., Orchard, T. J., Wagener, D. K., Becker, D. J., Cavender, D. E., & Drash, A. L. (1984). The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes, 33(3), 271–276.PubMedGoogle Scholar
  3. 3.
    Rewers, M. (2008). Why do people with diabetes die too soon? More questions than answers. Diabetes Care, 31(4), 830–832. doi:10.2337/dc08-0245.PubMedGoogle Scholar
  4. 4.
    Soedamah-Muthu, S. S., Fuller, J. H., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006). All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia, 49(4), 660–666. doi:10.1007/s00125-005-0120-4.PubMedGoogle Scholar
  5. 5.
    Dabelea, D., Bell, R. A., D'Agostino, R. B., Jr., Imperatore, G., Johansen, J. M., Linder, B., Liu, L. L., Loots, B., Marcovina, S., Mayer-Davis, E. J., Pettitt, D. J., & Waitzfelder, B. (2007). Incidence of diabetes in youth in the United States. Journal of the American Medical Association, 297(24), 2716–2724. doi:10.1001/jama.297.24.2716.PubMedGoogle Scholar
  6. 6.
    Narayan, K. M., Boyle, J. P., Thompson, T. J., Sorensen, S. W., & Williamson, D. F. (2003). Lifetime risk for diabetes mellitus in the United States. JAMA: The Journal of the American Medical Association, 290(14), 1884–1890.Google Scholar
  7. 7.
    Secrest, A.M., Becker, D.J., Kelsey, S.F., LaPorte, R.E., & Orchard, T.J. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care, 33(12), 2573–2579. doi:10.2337/dc10-1170
  8. 8.
    Harjutsalo, V., Forsblom, C., & Groop, P.H. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ, 343, d5364Google Scholar
  9. 9.
    Jarvisalo, M. J., Putto-Laurila, A., Jartti, L., Lehtimaki, T., Solakivi, T., Ronnemaa, T., & Raitakari, O. T. (2002). Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes, 51(2), 493–498.PubMedGoogle Scholar
  10. 10.
    Krantz, J. S., Mack, W. J., Hodis, H. N., Liu, C. R., Liu, C. H., & Kaufman, F. R. (2004). Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. Journal of Pediatrics, 145(4), 452–457. doi:10.1016/j.jpeds.2004.06.042.PubMedGoogle Scholar
  11. 11.
    Kostraba, J. N., Dorman, J. S., Orchard, T. J., Becker, D. J., Ohki, Y., Ellis, D., Doft, B. H., Lobes, L. A., LaPorte, R. E., & Drash, A. L. (1989). Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care, 12(10), 686–693.PubMedGoogle Scholar
  12. 12.
    Lawson, M. L., Sochett, E. B., Chait, P. G., Balfe, J. W., & Daneman, D. (1996). Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM. Diabetes, 45(1), 51–55.PubMedGoogle Scholar
  13. 13.
    Nadeau, K.J., Regensteiner, J.G., Bauer, T.A., Brown, M.S., Dorosz, J.L., Hull, A., Zeitler, P., Draznin, B., & Reusch, J.E. (2010, in press) Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. Journal of Pediatric Endocrinology & Metabolism, 95(2), 513–521. doi:10.1210/jc.2009-1756 Google Scholar
  14. 14.
    Snell-Bergeon, J. K., West, N. A., Mayer-Davis, E. J., Liese, A. D., Marcovina, S. M., D'Agostino, R. B., Jr., Hamman, R. F., & Dabelea, D. (2010). Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH case–control study. The Journal of Clinical Endocrinology and Metabolism, 95(6), 2868–2876. doi:10.1210/jc.2009-1993.PubMedGoogle Scholar
  15. 15.
    Brown, T., Snell-Bergeon, J.k.K., Maahs, D.M., & Wadwa, R.P. (2011) Loss of cardiovascular protection in women with type 1 diabetes may begin in adolescence. Diabetes Suppl, 267OR, July 2011Google Scholar
  16. 16.
    Nadeau, K., Draznin, B., Reusch, J., & Regensteiner, J. G. (2008). Gender differences in insulin sensitivity among youth with type 1 diabetes mellitus. Journal of Investigative Medicine, 56(1), 136.Google Scholar
  17. 17.
    Dabelea, D., Kinney, G., Snell-Bergeon, J. K., Hokanson, J. E., Eckel, R. H., Ehrlich, J., Garg, S., Hamman, R. F., & Rewers, M. (2003). Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes, 52(11), 2833–2839.PubMedGoogle Scholar
  18. 18.
    Colhoun, H. M., Rubens, M. B., Underwood, S. R., & Fuller, J. H. (2000). The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. Journal of the American College of Cardiology, 36(7), 2160–2167.PubMedGoogle Scholar
  19. 19.
    Suys, B. E., Katier, N., Rooman, R. P., Matthys, D., Op De Beeck, L., Du Caju, M. V., & De Wolf, D. (2004). Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care, 27(8), 1947–1953.PubMedGoogle Scholar
  20. 20.
    Samara-Boustani, D., Colmenares, A., Elie, C., Dabbas, M., Beltrand, J., Caron, V., Ricour, C., Jacquin, P., Tubiana-Rufi, N., Levy-Marchal, C., Delcroix, C., Martin, D., Benadjaoud, L., Jacqz Aigrain, E., Trivin, C., Laborde, K., Thibaud, E., Robert, J.J., & Polak, M. High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles. European Journal of Endocrinology, 166(2), 307–316. doi:10.1530/EJE-11-0670
  21. 21.
    Iniguez, G., Torrealba, I. M., Avila, A., Cassorla, F., & Codner, E. (2008). Adiponectin serum levels and their relationships to androgen concentrations and ovarian volume during puberty in girls with type 1 diabetes mellitus. Hormone Research, 70(2), 112–117. doi:10.1159/000137656.PubMedGoogle Scholar
  22. 22.
    Krolewski, A. S., Kosinski, E. J., Warram, J. H., Leland, O. S., Busick, E. J., Asmal, A. C., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987). Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. The American Journal of Cardiology, 59(8), 750–755.PubMedGoogle Scholar
  23. 23.
    Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003). Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care, 26(5), 1374–1379.PubMedGoogle Scholar
  24. 24.
    Lloyd, C. E., Kuller, L. H., Ellis, D., Becker, D. J., Wing, R. R., & Orchard, T. J. (1996). Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(6), 720–726.PubMedGoogle Scholar
  25. 25.
    Pambianco, G., Costacou, T., Ellis, D., Becker, D. J., Klein, R., & Orchard, T. J. (2006). The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes, 55(5), 1463–1469.PubMedGoogle Scholar
  26. 26.
    Koivisto, V. A., Stevens, L. K., Mattock, M., Ebeling, P., Muggeo, M., Stephenson, J., & Idzior-Walus, B. (1996). Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care, 19(7), 689–697.PubMedGoogle Scholar
  27. 27.
    Nathan, D. M., Cleary, P. A., Backlund, J. Y., Genuth, S. M., Lachin, J. M., Orchard, T. J., Raskin, P., & Zinman, B. (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine, 353(25), 2643–2653. doi:10.1056/NEJMoa052187.PubMedGoogle Scholar
  28. 28.
    Bjarnegard, N., Arnqvist, H. J., Lindstrom, T., Jonasson, L., Jonsson, A., & Lanne, T. (2009). Long-term hyperglycaemia impairs vascular smooth muscle cell function in women with type 1 diabetes mellitus. Diabetes & Vascular Disease Research: Official Journal of the International Society of Diabetes and Vascular Disease, 6(1), 25–31.Google Scholar
  29. 29.
    Heilman, K., Zilmer, M., Zilmer, K., Lintrop, M., Kampus, P., Kals, J., & Tillmann, V. (2009). Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes. Diabetes Research and Clinical Practice, 84(2), 168–173. doi:10.1016/j.diabres.2009.01.014.PubMedGoogle Scholar
  30. 30.
    Salem, M., El Behery, S., Adly, A., Khalil, D., & El Hadidi, E. (2009). Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes, 10(8), 513–521. doi:10.1111/j.1399-5448.2009.00517.x.PubMedGoogle Scholar
  31. 31.
    Jenkins, A. J., Lyons, T. J., Zheng, D., Otvos, J. D., Lackland, D. T., McGee, D., Garvey, W. T., & Klein, R. L. (2003). Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care, 26(3), 810–818.PubMedGoogle Scholar
  32. 32.
    Chait, A., & Bornfeldt, K. E. (2008). Diabetes and atherosclerosis: is there a role for hyperglycemia? Journal of Lipid Research. doi:10.1194/jlr.R800059-JLR200.
  33. 33.
    Purnell, J. Q., Hokanson, J. E., Marcovina, S. M., Steffes, M. W., Cleary, P. A., & Brunzell, J. D. (1998). Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. Journal of the American Medical Association, 280(2), 140–146.PubMedGoogle Scholar
  34. 34.
    Nadeau, K.J., Zeitler, P.S., Bauer, T.A., Brown, M.S., Dorosz, J.L., Draznin, B., Regensteiner, J.G., & Reusch, J.E.B. (2009) Insulin resistance in adolescents with Type 2 diabetes is associated with impaired exercise capacity. JCEM Online, ahead of printGoogle Scholar
  35. 35.
    Haller, M. J., Stein, J., Shuster, J., Theriaque, D., Silverstein, J., Schatz, D. A., Earing, M. G., Lerman, A., & Mahmud, F. H. (2007). Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Pediatric Diabetes, 8(4), 193–198.PubMedGoogle Scholar
  36. 36.
    Gusso, S., Hofman, P., Lalande, S., Cutfield, W., Robinson, E., & Baldi, J. C. (2008). Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus. Diabetologia, 51(7), 1317–1320. doi:10.1007/s00125-008-1012-1.PubMedGoogle Scholar
  37. 37.
    Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M. (2011). Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes, 60(1), 306–314. doi:10.2337/db10-0328.PubMedGoogle Scholar
  38. 38.
    Nadeau, K.J., Regensteiner, J.G., Bauer, T.A., Brown, M.S., Dorosz, J.L., Hull, A., Zeitler, P., Draznin, B., & Reusch, J.E. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. Journal of Pediatric Endocrinology & Metabolism, 95(2), 513–521. doi:10.1210/jc.2009-1756
  39. 39.
    Dabelea, D., D'Agostino, R.B., Jr., Mason, C.C., West, N., Hamman, R.F., Mayer-Davis, E.J., Maahs, D., Klingensmith, G., Knowler, W.C., & Nadeau, K. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for diabetes in youth study. Diabetologia, 54(1), 78–86. doi:10.1007/s00125-010-1911-9
  40. 40.
    Specht, B.J., Wadwa, R.P., Snell-Bergeon, J.K., Bishop, F.K., & Maahs, D.M. (2012) Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes submitted to ADA meeting, 2012Google Scholar
  41. 41.
    Bishop, F. K., Maahs, D. M., Snell-Bergeon, J. K., Ogden, L. G., Kinney, G. L., & Rewers, M. (2009). Lifestyle risk factors for atherosclerosis in adults with type 1 diabetes. Diabetes & Vascular Disease Research: Official Journal of the International Society of Diabetes and Vascular Disease, 6(4), 269–275. doi:10.1177/1479164109346359.Google Scholar
  42. 42.
    Schauer, I.E., Snell-Bergeon, J.K., Bergman, B.C., Maahs, D.M., Kretowski, A., Eckel, R.H., & Rewers, M. (2010, in press) Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes. doi:10.2337/db10-0328
  43. 43.
    Maahs, D. M., Hokanson, J. E., Wang, H., Kinney, G. L., Snell-Bergeon, J. K., East, A., Bergman, B. C., Schauer, I. E., Rewers, M., & Eckel, R. H. (2010). Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance. Diabetes, 59(7), 1771–1779. doi:10.2337/db09-1626.PubMedGoogle Scholar
  44. 44.
    Farkas, K., Jermendy, G., Herold, M., Ruzicska, E., Sasvari, M., & Somogyi, A. (2004). Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes, 112(5), 258–263. doi:10.1055/s-2004-817973.Google Scholar
  45. 45.
    Horoz, O. O., Yuksel, B., Bayazit, A. K., Attila, G., Sertdemir, Y., Mungan, N. O., Topaloglu, A. K., & Ozer, G. (2009). Ambulatory blood pressure monitoring and serum nitric oxide concentration in type 1 diabetic children. Endocrine Journal, 56(3), 477–485.PubMedGoogle Scholar
  46. 46.
    Huemer, M., Simma, B., Mayr, D., Muhl, A., Rami, B., Schober, E., Ulmer, H., Zanier, U., & Bodamer, O.A. Low levels of asymmetric dimethylarginine in children with diabetes mellitus type I compared with healthy children. Journal of Pediatric, 158(4), 602–606 e601. doi:10.1016/j.jpeds.2010.09.058
  47. 47.
    Battelino, N., Sebestjen, M., Keber, I., Blagus, R., Hovnik, T., Bratina, N., & Battelino, T. Endothelial nitric oxide synthase T(−786)C polymorphism in children and adolescents with type 1 diabetes and impaired endothelium-dependent dilatation. Hormone Research Pediatric, 76(4), 248–253. doi:10.1159/000329549
  48. 48.
    Zineh, I., Beitelshees, A. L., & Haller, M. J. (2007). NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes. Diabetes Care, 30(3), 689–693. doi:10.2337/dc06-1697.PubMedGoogle Scholar
  49. 49.
    Chan, N. N., Vallance, P., & Colhoun, H. M. (2000). Nitric oxide and vascular responses in type I diabetes. Diabetologia, 43(2), 137–147. doi:10.1007/s001250050022.PubMedGoogle Scholar
  50. 50.
    MacKenzie, K. E., Wiltshire, E. J., Pena, A. S., Gent, R., Hirte, C., Piotto, L., & Couper, J. J. (2009). Hs-CRP is associated with weight, BMI, and female sex but not with endothelial function in children with type 1 diabetes. Pediatric Diabetes, 10(1), 44–51. doi:10.1111/j.1399-5448.2008.00456.x.PubMedGoogle Scholar
  51. 51.
    Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Aponte, J. E., Jacobson, A. M., & Cole, C. F. (1994). Insulin omission in women with IDDM. Diabetes Care, 17(10), 1178–1185.PubMedGoogle Scholar
  52. 52.
    Olmsted, M. P., Colton, P. A., Daneman, D., Rydall, A. C., & Rodin, G. M. (2008). Prediction of the onset of disturbed eating behavior in adolescent girls with type 1 diabetes. Diabetes Care, 31(10), 1978–1982.PubMedGoogle Scholar
  53. 53.
    Margeirsdottir, H.D., Stensaeth, K.H., Larsen, J.R., Brunborg, C., & Dahl-Jorgensen, K. (2010, In Press) Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study. Diabetes Care, 33(9), 2043–2048. doi: 10.2337/dc10-0505 Google Scholar
  54. 54.
    Taskinen, M. R., & Nikkila, E. A. (1979). Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low-density lipoproteins and response to treatment. Diabetologia, 17(6), 351–356.PubMedGoogle Scholar
  55. 55.
    Maahs, D. M., Wadwa, R. P., McFann, K., Nadeau, K., Williams, M. R., Eckel, R. H., & Klingensmith, G. J. (2007). Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes. Journal of Pediatrics, 150(2), 146–150. doi:10.1016/j.jpeds.2006.10.054. 150 e141-142.PubMedGoogle Scholar
  56. 56.
    Schwab, K.O., Doerfer, J., Marg, W., Schober, E., & Holl, R.W. (2010, in press) Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors. Pediatric Diabetes, 11(5), 357–363. doi:10.1111/j.1399-5448.2010.00665.x Google Scholar
  57. 57.
    Petitti, D. B., Imperatore, G., Palla, S. L., Daniels, S. R., Dolan, L. M., Kershnar, A. K., Marcovina, S., Pettitt, D. J., & Pihoker, C. (2007). Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Archives of Pediatrics & Adolescent Medicine, 161(2), 159–165. doi:10.1001/archpedi.161.2.159.Google Scholar
  58. 58.
    Groop, P. H., Thomas, M. C., Rosengard-Barlund, M., Mills, V., Ronnback, M., Thomas, S., Forsblom, C., Taskinen, M. R., & Viberti, G. (2007). HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care, 30(10), 2706–2707. doi:10.2337/dc07-0030.PubMedGoogle Scholar
  59. 59.
    Jarvisalo, M. J., Raitakari, M., Toikka, J. O., Putto-Laurila, A., Rontu, R., Laine, S., Lehtimaki, T., Ronnemaa, T., Viikari, J., & Raitakari, O. T. (2004). Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation, 109(14), 1750–1755. doi:10.1161/01.CIR.0000124725.46165.2C.PubMedGoogle Scholar
  60. 60.
    Singh, T. P., Groehn, H., & Kazmers, A. (2003). Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. Journal of the American College of Cardiology, 41(4), 661–665.PubMedGoogle Scholar
  61. 61.
    Harrington, J., Pena, A.S., Gent, R., Hirte, C., & Couper, J. (2010, in press) Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. Journal of Pediatrics, 156(2), 237–241. doi:10.1016/j.jpeds.2009.08.036 Google Scholar
  62. 62.
    Collado-Mesa, F., Colhoun, H. M., Stevens, L. K., Boavida, J., Ferriss, J. B., Karamanos, B., Kempler, P., Michel, G., Roglic, G., & Fuller, J. H. (1999). Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study. Diabetic Medicine: A Journal of the British Diabetic Association, 16(1), 41–48.Google Scholar
  63. 63.
    Lee, S. H., Kim, J. H., Kang, M. J., Lee, Y. A., Won Yang, S., & Shin, C. H. (2011). Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care, 34(10), 2180–2185.PubMedGoogle Scholar
  64. 64.
    Perrin, N. E., Torbjornsdotter, T., Jaremko, G. A., & Berg, U. B. (2010). Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients. Pediatric Diabetes, 11(5), 305–313.PubMedGoogle Scholar
  65. 65.
    Rossing, P., Hougaard, P., Borch-Johnsen, K., & Parving, H. H. (1996). Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ, 313(7060), 779–784.PubMedGoogle Scholar
  66. 66.
    Gay, E. C., Cai, Y., Gale, S. M., Baron, A., Cruickshanks, K. J., Kostraba, J. N., & Hamman, R. F. (1992). Smokers with IDDM experience excess morbidity. The Colorado IDDM Registry. Diabetes Care, 15(8), 947–952.PubMedGoogle Scholar
  67. 67.
    Polak, J.F., Backlund, J.Y., Cleary, P.A., Harrington, A.P., O’Leary, D.H., Lachin, J.M., & Nathan, D.M. Progression of carotid artery intima-media thickness during 12 years in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes, 60(2), 607–613. doi:10.2337/db10-0296
  68. 68.
    Prince, C.T., Secrest, A.M., Mackey, R.H., Arena, V.C., Kingsley, L.A., & Orchard, T.J. Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care, 33(3), 652–657. doi:10.2337/dc09-1936
  69. 69.
    Salem, M., Moneir, I., Adly, A.M., & Esmat, K. Study of coronary artery calcification risk in Egyptian adolescents with type-1 diabetes. Acta Diabetologica, 48(1), 41–53. doi:10.1007/s00592-010-0214-4
  70. 70.
    Reynolds, K., Liese, A.D., Anderson, A.M., Dabelea, D., Standiford, D., Daniels, S.R., Waitzfelder, B., Case, D., Loots, B., Imperatore, G., & Lawrence, J.M. Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus. Journal of Pediatric, 158(4), 594–601 e591. doi:10.1016/j.jpeds.2010.10.011
  71. 71.
    Schwab, K. O., Doerfer, J., Hecker, W., Grulich-Henn, J., Wiemann, D., Kordonouri, O., Beyer, P., & Holl, R. W. (2006). Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care, 29(2), 218–225.PubMedGoogle Scholar
  72. 72.
    Borch-Johnsen, K., & Kreiner, S. (1987). Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. British Medical Journal (Clinical Research Ed.), 294(6588), 1651–1654.Google Scholar
  73. 73.
    Gale, E. A. (1999). Prevention studies in type 1 diabetes. Experimental and Clinical Endocrinology & Diabetes, 107(Suppl 3), S101.Google Scholar
  74. 74.
    Gibb, D. M., Dunger, D., Levin, M., Shah, V., Smith, C., & Barratt, T. M. (1989). Early markers of the renal complications of insulin dependent diabetes mellitus. Archives of Disease in Childhood, 64(7), 984–991.PubMedGoogle Scholar
  75. 75.
    Mortensen, H. B., Marinelli, K., Norgaard, K., Main, K., Kastrup, K. W., Ibsen, K. K., Villumsen, J., & Parving, H. H. (1990). A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabetic Medicine: A Journal of the British Diabetic Association, 7(10), 887–897.Google Scholar
  76. 76.
    Quattrin, T., Waz, W. R., Duffy, L. C., Sheldon, M. W., Campos, S. P., Albini, C. H., & Feld, L. G. (1995). Microalbuminuria in an adolescent cohort with insulin-dependent diabetes mellitus. Clinical Pediatrics (Phila), 34(1), 12–17.Google Scholar
  77. 77.
    Salardi, S., Cacciari, E., Pascucci, M. G., Giambiasi, E., Tacconi, M., Tazzari, R., Cicognani, A., Boriani, F., Puglioli, R., Mantovani, W., et al. (1990). Microalbuminuria in diabetic children and adolescents. Relationship with puberty and growth hormone. Acta Paediatrica Scandinavica, 79(4), 437–443.PubMedGoogle Scholar
  78. 78.
    Schultz, C. J., Neil, H. A., Dalton, R. N., Konopelska Bahu, T., & Dunger, D. B. (2001). Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care, 24(3), 555–560.PubMedGoogle Scholar
  79. 79.
    Abraha, A., Schultz, C., Konopelska-Bahu, T., James, T., Watts, A., Stratton, I. M., Matthews, D. R., & Dunger, D. B. (1999). Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood Diabetes. Diabetic Medicine: A Journal of the British Diabetic Association, 16(7), 598–604.Google Scholar
  80. 80.
    Orchard, T. J., Forrest, K. Y., Kuller, L. H., & Becker, D. J. (2001). Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care, 24(6), 1053–1059.PubMedGoogle Scholar
  81. 81.
    Groop, P. H., Elliott, T., Ekstrand, A., Franssila-Kallunki, A., Friedman, R., Viberti, G. C., & Taskinen, M. R. (1996). Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes, 45(7), 974–979.PubMedGoogle Scholar
  82. 82.
    Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989). Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia, 32(4), 219–226.PubMedGoogle Scholar
  83. 83.
    Tuomilehto, J., Borch-Johnsen, K., Molarius, A., Forsen, T., Rastenyte, D., Sarti, C., & Reunanen, A. (1998). Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia, 41(7), 784–790.PubMedGoogle Scholar
  84. 84.
    Chaturvedi, N., Fuller, J. H., & Taskinen, M. R. (2001). Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care, 24(12), 2071–2077.PubMedGoogle Scholar
  85. 85.
    Thorn, L. M., Forsblom, C., Fagerudd, J., Thomas, M. C., Pettersson-Fernholm, K., Saraheimo, M., Waden, J., Ronnback, M., Rosengard-Barlund, M., Bjorkesten, C. G., Taskinen, M. R., & Groop, P. H. (2005). Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care, 28(8), 2019–2024.PubMedGoogle Scholar
  86. 86.
    Schweiger, B., Klingensmith, G., & Snell-Bergeon, J. K. (2010). Physical activity in adolescent females with type 1 diabetes. International Journal of Pediatrics, 2010, 328318. doi:10.1155/2010/328318.PubMedGoogle Scholar
  87. 87.
    Aman, J., Skinner, T. C., de Beaufort, C. E., Swift, P. G., Aanstoot, H. J., & Cameron, F. (2009). Associations between physical activity, sedentary behavior, and glycemic control in a large cohort of adolescents with type 1 diabetes: the Hvidoere Study Group on Childhood Diabetes. Pediatric Diabetes, 10(4), 234–239. doi:10.1111/j.1399-5448.2008.00495.x.PubMedGoogle Scholar
  88. 88.
    Tattersall, R. B., & Gill, G. V. (1991). Unexplained deaths of type 1 diabetic patients. Diabetic Medicine: A Journal of the British Diabetic Association, 8(1), 49–58.Google Scholar
  89. 89.
    Sartor, G., & Dahlquist, G. (1995). Short-term mortality in childhood onset insulin-dependent diabetes mellitus: a high frequency of unexpected deaths in bed. Diabetic Medicine: A Journal of the British Diabetic Association, 12(7), 607–611.Google Scholar
  90. 90.
    Thordarson, H., & Sovik, O. (1995). Dead in bed syndrome in young diabetic patients in Norway. Diabetic Medicine: A Journal of the British Diabetic Association, 12(9), 782–787.Google Scholar
  91. 91.
    Gill, G. V., Woodward, A., Casson, I. F., & Weston, P. J. (2009). Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes–the ‘dead in bed’ syndrome revisited. Diabetologia, 52(1), 42–45.PubMedGoogle Scholar
  92. 92.
    Rothenbuhler, A., Bibal, C. P., Le Fur, S., & Bougneres, P. (2008). Effects of a controlled hypoglycaemia test on QTc in adolescents with type 1 diabetes. Diabetic Medicine: A Journal of the British Diabetic Association, 25(12), 1483–1485.Google Scholar
  93. 93.
    Vallance, P., Calver, A., & Collier, J. (1992). The vascular endothelium in diabetes and hypertension. Journal of Hypertension Supplement, 10(1), S25–S29.Google Scholar
  94. 94.
    Pena, A. S., Wiltshire, E., MacKenzie, K., Gent, R., Piotto, L., Hirte, C., & Couper, J. (2006). Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children. Journal of Clinical Endocrinology and Metabolism, 91(11), 4467–4471. doi:10.1210/jc.2006-0863.PubMedGoogle Scholar
  95. 95.
    Trigona, B., Aggoun, Y., Maggio, A., Martin, X.E., Marchand, L.M., & Beghetti, M., Farpour-Lambert NJ (2010, In press) Preclinical noninvasive markers of atherosclerosis in children and adolescents with type 1 diabetes are influenced by physical activity. Journal of Pediatric, 157(4), 533–539. doi:10.1016/j.jpeds.2010.04.023 Google Scholar
  96. 96.
    Vazquez, B.Y., Vazquez, M.A., Jaquez, M.G., Huemoeller, A.H., Intaglietta, M., & Cabrales, P. (2010, In Press) Blood pressure directly correlates with blood viscosity in diabetes type 1 children but not in normals. Clinical Hemorheology and Microcirculation, 44(1), 55–61. doi:10.3233/CH-2010-1252 Google Scholar
  97. 97.
    Prince, C.T., Secrest, A.M., Mackey, R.H., Arena, V.C., Kingsley, L.A.,& Orchard, T.J. (2010, in press) Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes. Atherosclerosis. doi:10.1016/j.atherosclerosis.2010.08.080
  98. 98.
    Ahlgren, A. R., Astrand, H., Sundkvist, G., & Lanne, T. (2005). Increased aortic stiffness is persistent in type 1 diabetic women: a follow-up study. Diabetologia, 48(4), 780–783. doi:10.1007/s00125-005-1685-7.PubMedGoogle Scholar
  99. 99.
    Prince, C. T., Secrest, A. M., Mackey, R. H., Arena, V. C., Kingsley, L. A., & Orchard, T. J. (2010). Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes. Atherosclerosis, 213(2), 469–474.PubMedGoogle Scholar
  100. 100.
    Wilhelm, B., Weber, M. M., Kreisselmeier, H. P., Kugler, M., Ries, C., Pfutzner, A., Kann, P. H., & Forst, T. (2007). Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp. Journal of Diabetes Science and Technology, 1(4), 582–589.PubMedGoogle Scholar
  101. 101.
    Haller, M. J., Samyn, M., Nichols, W. W., Brusko, T., Wasserfall, C., Schwartz, R. F., Atkinson, M., Shuster, J. J., Pierce, G. L., & Silverstein, J. H. (2004). Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care, 27(12), 2911–2917.PubMedGoogle Scholar
  102. 102.
    Stakos, D. A., Schuster, D. P., Sparks, E. A., Wooley, C. F., Osei, K., & Boudoulas, H. (2005). Cardiovascular effects of type 1 diabetes mellitus in children. Angiology, 56(3), 311–317.PubMedGoogle Scholar
  103. 103.
    Urbina, E.M., Wadwa, R.P., Davis, C., Snively, B.M., Dolan, L.M., Daniels, S.R., Hamman, R.F., & Dabelea, D. (2010, In Press) Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study. Journal of Pediatric, 156(5), 731–737, 737 e731. doi:10.1016/j.jpeds.2009.11.011 Google Scholar
  104. 104.
    Wadwa, R.P., Urbina, E.M., Anderson, A.M., Hamman, R.F., Dolan, L.M., Rodriguez, B.L., Daniels, S.R., & Dabelea, D. (2010, In Press) Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care, 33(4), 881–886. doi:10.2337/dc09-0747
  105. 105.
    Gallo, L.M., Silverstein, J.H., Shuster, J.J., & Haller, M.J. (2010, In Press) Arterial stiffness, lipoprotein particle size, and lipoprotein particle concentration in children with type 1 diabetes. Journal of Pediatric Endocrinology & Metabolism, 23(7), 661–667Google Scholar
  106. 106.
    Godsland, I.F., Pavitt, D., Okoturo, O., Edwards, R.J., Rubens, M.B., Feher, M.D., Flather, M.D., & Elkeles, R.S. (2010, In Press) Can protein biomarkers provide an index of coronary artery calcification in patients with type 2 diabetes? Atherosclerosis. doi:10.1016/j.atherosclerosis.2010.09.002
  107. 107.
    Jarvisalo, M. J., Jartti, L., Nanto-Salonen, K., Irjala, K., Ronnemaa, T., Hartiala, J. J., Celermajer, D. S., & Raitakari, O. T. (2001). Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation, 104(24), 2943–2947.PubMedGoogle Scholar
  108. 108.
    Atabek, M. E., Pirgon, O., Kurtoglu, S., & Imamoglu, H. (2006). Evidence for an association between type 1 diabetes and premature carotid atherosclerosis in childhood. Pediatric Cardiology, 27(4), 428–433.PubMedGoogle Scholar
  109. 109.
    Peppa-Patrikiou, M., Scordili, M., Antoniou, A., Giannaki, M., Dracopoulou, M., & Dacou-Voutetakis, C. (1998). Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care, 21(6), 1004–1007.PubMedGoogle Scholar
  110. 110.
    Zarich, S. W., Arbuckle, B. E., Cohen, L. R., Roberts, M., & Nesto, R. W. (1988). Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. Journal of the American College of Cardiology, 12(1), 114–120.PubMedGoogle Scholar
  111. 111.
    Muranaka, A., Yuda, S., Tsuchihashi, K., Hashimoto, A., Nakata, T., Miura, T., Tsuzuki, M., Wakabayashi, C., Watanabe, N., & Shimamoto, K. (2009). Quantitative assessment of left ventricular and left atrial functions by strain rate imaging in diabetic patients with and without hypertension. Echocardiography, 26(3), 262–271. doi:10.1111/j.1540-8175.2008.00805.x.PubMedGoogle Scholar
  112. 112.
    Karavanaki, K., Kazianis, G., Konstantopoulos, I., Tsouvalas, E., & Karayianni, C. (2008). Early signs of left ventricular dysfunction in adolescents with type 1 diabetes mellitus: the importance of impaired circadian modulation of blood pressure and heart rate. Journal of Endocrinological Investigation, 31(4), 289–296.PubMedGoogle Scholar
  113. 113.
    Shen, X., Zheng, S., Thongboonkerd, V., Xu, M., Pierce, W. M., Jr., Klein, J. B., & Epstein, P. N. (2004). Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. American Journal of Physiology, Endocrinology and Metabolism, 287(5), E896–E905. doi:10.1152/ajpendo.00047.2004.Google Scholar
  114. 114.
    Hassouna, A., Loubani, M., Matata, B. M., Fowler, A., Standen, N. B., & Galinanes, M. (2006). Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovascular Research, 69(2), 450–458. doi:10.1016/j.cardiores.2005.11.004.PubMedGoogle Scholar
  115. 115.
    Baldi, J.C., Cassuto, N.A., Foxx-Lupo, W.T., Wheatley, C.M., & Snyder, E.M. (2010, in press) Glycemic status affects cardiopulmonary exercise response in athletes with type I diabetes. Medicine & Science in Sports & Exercise, 42(8), 1454–1459. doi:10.1249/MSS.0b013e3181d1fdb3
  116. 116.
    Rowland, T. W., Martha, P. M., Jr., Reiter, E. O., & Cunningham, L. N. (1992). The influence of diabetes mellitus on cardiovascular function in children and adolescents. International Journal of Sports Medicine, 13(5), 431–435.PubMedGoogle Scholar
  117. 117.
    Kimball, T. R., Daniels, S. R., Khoury, P. R., Magnotti, R. A., Turner, A. M., & Dolan, L. M. (1994). Cardiovascular status in young patients with insulin-dependent diabetes mellitus. Circulation, 90(1), 357–361.PubMedGoogle Scholar
  118. 118.
    Lucini, D., Zuccotti, G., Malacarne, M., Scaramuzza, A., Riboni, S., Palombo, C., & Pagani, M. (2009). Early progression of the autonomic dysfunction observed in pediatric type 1 diabetes mellitus. Hypertension, 54(5), 987–994. doi:10.1161/HYPERTENSIONAHA.109.140103.PubMedGoogle Scholar
  119. 119.
    Dorosz, J.L., Salcedo, E.E., Regensteiner, J.G., & Nadeau, K.J. (2009) Sub-clinical cardiac dysfunction in adolescents with T1DM detected by tissue velocities as measured by tissue tracking. American Society of Echocardiography Annual Scientific Sessions.Google Scholar
  120. 120.
    Lopes-Virella, M. F., McHenry, M. B., Lipsitz, S., Yim, E., Wilson, P. F., Lackland, D. T., Lyons, T., Jenkins, A. J., & Virella, G. (2007). Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis, 190(2), 359–369. doi:10.1016/j.atherosclerosis.2006.02.007.PubMedGoogle Scholar
  121. 121.
    Klein, R.L., Carter, R.E., Jenkins, A.J., Lyons, T.J., Baker, N.L., Gilbert, G.E., Virella, G., & Lopes-Virella, M.F. (2010, In Press) LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. Journal of Diabetic Complications. doi:10.1016/j.jdiacomp.2010.03.001
  122. 122.
    DiMeglio, L.A., Tosh, A., Saha, C., Estes, M., Mund, J., Mead, L.E., Lien, I., Ingram, D.A., & Haneline, L.S. (2010, In Press) Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? Journal of Pediatric, 157(4):540–546. doi:10.1016/j.jpeds.2010.04.050 Google Scholar
  123. 123.
    McKittrick, I. B., Bogaert, Y., Nadeau, K., Snell-Bergeon, J., Hull, A., Jiang, T., Wang, X., Levi, M., & Moulton, K. S. (2011). Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes. American Journal of Physiology. Renal Physiology, 301(6), F1326–F1333.PubMedGoogle Scholar
  124. 124.
    D'hooge, R., Hellinckx, T., Van Laethem, C., Stegen, S., De Schepper, J., Van Aken, S., Dewolf, D., & Calders, P. (2011). Influence of combined aerobic and resistance training on metabolic control, cardiovascular fitness and quality of life in adolescents with type 1 diabetes: a randomized controlled trial. Clinical Rehabilitation, 25(4), 349–359.PubMedGoogle Scholar
  125. 125.
    Lehmann, R., Kaplan, V., Bingisser, R., Bloch, K. E., & Spinas, G. A. (1997). Impact of physical activity on cardiovascular risk factors in IDDM. Diabetes Care, 20(10), 1603–1611.PubMedGoogle Scholar
  126. 126.
    Aouadi, R., Khalifa, R., Aouidet, A., Ben Mansour, A., Ben Rayana, M., Mdini, F., Bahri, S., & Stratton, G. (2011). Aerobic training programs and glycemic control in diabetic children in relation to exercise frequency. The Journal of Sports Medicine and Physical Fitness, 51(3), 393–400.PubMedGoogle Scholar
  127. 127.
    Salem, M. A., Aboelasrar, M. A., Elbarbary, N. S., Elhilaly, R. A., & Refaat, Y. M. (2010). Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial. Diabetology and Metabolic Syndrome, 2(1), 47.PubMedGoogle Scholar
  128. 128.
    MacKenzie, K. E., Wiltshire, E. J., Gent, R., Hirte, C., Piotto, L., & Couper, J. J. (2006). Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics, 118(1), 242–253. doi:10.1542/peds.2005-2143.PubMedGoogle Scholar
  129. 129.
    Pena, A. S., Wiltshire, E., Gent, R., Hirte, C., & Couper, J. (2004). Folic acid improves endothelial function in children and adolescents with type 1 diabetes. Journal of Pediatrics, 144(4), 500–504. doi:10.1016/j.jpeds.2003.12.049.PubMedGoogle Scholar
  130. 130.
    Jehlicka, P., Stozicky, F., Mayer, O., Jr., Varvarovska, J., Racek, J., Trefil, L., & Siala, K. (2009). Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1. Physiological Research, 58(2), 179–184.PubMedGoogle Scholar
  131. 131.
    Pena, A. S., Wiltshire, E., Gent, R., Piotto, L., Hirte, C., & Couper, J. (2007). Folic acid does not improve endothelial function in obese children and adolescents. Diabetes Care, 30(8), 2122–2127. doi:10.2337/dc06-2505.PubMedGoogle Scholar
  132. 132.
    Mullen, M. J., Wright, D., Donald, A. E., Thorne, S., Thomson, H., & Deanfield, J. E. (2000). Atorvastatin but not l-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. Journal of the American College of Cardiology, 36(2), 410–416.PubMedGoogle Scholar
  133. 133.
    Haller, M. J., Stein, J. M., Shuster, J. J., Theriaque, D., Samyn, M. M., Pepine, C., & Silverstein, J. H. (2009). Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism, 22(1), 65–68.Google Scholar
  134. 134.
    Adolescent type 1 Diabetes cardio-renal Intervention Trial Research G. (2009). Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatrics, 9, 79. doi:10.1186/1471-2431-9-79.Google Scholar
  135. 135.
    Wiernsperger, N. F., & Bailey, C. J. (1999). The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs, 58(Suppl 1), 31–39. discussion 75–82.PubMedGoogle Scholar
  136. 136.
    Hamilton, J., Cummings, E., Zdravkovic, V., Finegood, D., & Daneman, D. (2003). Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care, 26(1), 138–143.PubMedGoogle Scholar
  137. 137.
    Sarnblad, S., Kroon, M., & Aman, J. (2003). Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. European Journal of Endocrinology/European Federation of Endocrine Societies, 149(4), 323–329.PubMedGoogle Scholar
  138. 138.
    Abdelghaffar, S., & Attia, A.M. (2009) Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents. Cochrane Database Syst Rev (1):CD006691Google Scholar
  139. 139.
    Moon, R. J., Bascombe, L. A., & Holt, R. I. (2007). The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being. Diabetes, Obesity & Metabolism, 9(1), 143–145.Google Scholar
  140. 140.
    Walravens, P., Chase, P., Klingensmith, G., Ellison, M., Cornell, C., & Monohan, K. (2000) Low dose metformin in adolescents with type 1 diabetes mellitus: a double blind controlled study. Diabetes Suppl, 510P, July 2000Google Scholar
  141. 141.
    Vella, S., Buetow, L., Royle, P., Livingstone, S., Colhoun, H. M., & Petrie, J. R. (2010). The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia, 53(5), 809–820.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Barbara Davis Center for Childhood DiabetesUniversity of Colorado Anschutz Medical CenterAuroraUSA
  2. 2.Colorado School of Public HealthUniversity of Colorado Anschutz Medical CenterAuroraUSA
  3. 3.Department of Pediatric EndocrinologyUniversity of Colorado Anschutz Medical CenterAuroraUSA

Personalised recommendations